FDA 483 OBSERVATION · #112 OF 1,923 MOST-CITED
Training--operations, GMPs, written procedures
FDA cited this observation 266 times across 244 firms in recent inspections. Below: how it breaks down by program area and fiscal year, and real examples of how FDA worded it on Form FDA 483.
What this grouping is not
An observation-type page groups FDA’s published citation records. The grouping, the compliance steps and the root causes are SPEQ synthesis, not an FDA classification of any citation, and a count measures what FDA published rather than risk.
What this observation means, and how to comply
SPEQ's practitioner reading of this finding. The regulatory basis is a cited fact; the interpretation, compliance steps, and root causes are SPEQ synthesis — not an FDA classification of the citation.
Human-food CGMP requires supervisory and production personnel to be trained in the specific operations they run, in current good manufacturing practices, and in the plant’s written procedures — training scoped to the actual job, not generic awareness.
Why FDA writes it — FDA cites this when staff operate equipment or execute processes without training on the governing SOPs and CGMPs, because a worker who does not know the written procedure will improvise, and improvisation around food safety is where deviations and contamination begin.
- Train each operator on the specific written procedures for the operations they perform, not just general hygiene.
- Cover CGMP requirements and the plant’s SOPs, with retraining when procedures are revised.
- Document training against each procedure so you can show which employees were trained on which current SOP version.
- Generic annual GMP training that never maps to the individual SOPs an employee actually executes.
- Procedures get revised but affected staff are not retrained, leaving them working to an outdated method.
How to close this finding — and stop it recurring
What this observation is associated with
Firms cited for this observation also appear in FDA compliance actions — warning letters, injunctions, or seizures — at 4.9× the rate of the average FDA-cited firm (38.1% vs 7.8%), across 244 FEI-matched firms.
This is an association, not causation, and reflects co-occurrence in FDA's records — not a claim that the observation caused or preceded the action.
How FDA worded it — real examples
Employees are not given training in the particular operations they perform as part of their function and written procedures required by current good manufacturing practice regulations.
Employees are not given training in current good manufacturing practices.
Employees are not given training in the particular operations they perform as part of their function.
Employees are not given training in the particular operations they perform as part of their function.
Employees are not given training in the particular operations they perform as part of their function and current good manufacturing practices.
Employees are not given training in the particular operations they perform as part of their function and current good manufacturing practices.
Related SPEQ references
Where to read the requirements behind this observation area on SPEQ. These are SPEQ's topic and audience pages — not an FDA classification of the citation.
Examples are a representative sample of FDA's published inspection observations. Open the 483 observation explorer →